Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immune response to hepatitis B revaccination.

W Jilg1, M Schmidt, F Deinhardt

  • 1Max von Pettenkofer Institute for Hygiene and Medical Microbiology, University of Munich, Federal Republic of Germany.

Journal of Medical Virology
|April 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence of human T-cell lymphotropic virus infections in Germany.

Journal of medical virology·1994
Same author

[A new variant of the simian T-lymphotropic retrovirus type I (STLV-IF) in the Sukhumi colony of hamadryas baboons].

Voprosy virusologii·1993
Same author

Production of human cloned antibodies specific for hepatitis D virus-encoded small and large protein.

Journal of hepatology·1993
Same author

Principal neutralizing domain of HIV-1 is highly immunogenic when expressed on the surface of hepatitis B core particles.

Vaccine·1993
Same author

The immune response to different doses of inactivated hepatitis A vaccine.

Journal of hepatology·1993
Same author

Different iron-chelating properties of aminosalicylates.

Gastroenterology·1992
Same journal

JQKD82 Inhibits HIV Infection of Macrophages Through Blocking Viral Entry and Enhancing Antiviral ISG Responses.

Journal of medical virology·2026
Same journal

Commentary on "Broadly Protective Antibody-Like Vaccines Against Highly Pathogenic Coronaviruses".

Journal of medical virology·2026
Same journal

Torque Teno Virus Dynamics in Plasma and BAL of COVID-19 ARDS Patients With and Without ECMO.

Journal of medical virology·2026
Same journal

Comprehensive Evaluation of the Elecsys HCV Duo Immunoassay for Active Hepatitis C Detection: Insights From the DEPCDUO Study.

Journal of medical virology·2026
Same journal

The Impact of Admission Viral Load and Inflammatory Markers on Mortality and Prognosis in Crimean-Congo Hemorrhagic Fever.

Journal of medical virology·2026
Same journal

A One-Pot CRISPR-Cas12b Assay for Rapid Detection of Human Adenovirus Serotypes 3 and 7.

Journal of medical virology·2026
See all related articles

Hepatitis B revaccination is effective for non-responders and those with waning immunity. Booster doses significantly increase anti-HBs levels and antibody persistence, improving long-term protection.

Area of Science:

  • Immunology
  • Vaccinology
  • Public Health

Background:

  • Hepatitis B vaccination is crucial for preventing infection.
  • Some individuals fail to respond or lose immunity over time.
  • Assessing revaccination strategies is important for sustained protection.

Purpose of the Study:

  • To evaluate the efficacy of revaccination in individuals with suboptimal response to hepatitis B vaccine.
  • To assess antibody persistence and titres after revaccination and booster doses.

Main Methods:

  • Revaccination of 212 individuals with poor or lost response to initial hepatitis B vaccine.
  • Measurement of anti-HBs levels before and after revaccination.
  • Analysis of antibody titres and persistence after multiple immunizations.

Related Experiment Videos

Main Results:

  • 18% of initial non-responders and 96% of initial responders achieved protective anti-HBs levels after revaccination.
  • Fourth immunization resulted in significantly higher anti-HBs titres compared to the primary course.
  • Antibody levels persisted better after revaccination, and previously undetectable antibodies reappeared.

Conclusions:

  • Hepatitis B revaccination is highly effective in inducing protective antibody levels.
  • Booster doses enhance anti-HBs titres and improve long-term antibody persistence.
  • Revaccination strategies are vital for maintaining long-term immunity against Hepatitis B.